Where It All Began:For those who are not aware of it’s history, the start of this new Institute in 2007 was pivotal for the University, and for our State to remain ‘The Big House’ in genetics. For it was in Maryland that the modern field of genomics emerged during a time where the state was at the epicenter of genomic innovation and picked up the nickname ‘DNA Valley’. It was in 1990 in Montgomery County, MD that the national Human Genome Project (HGP) was started with the moonshot goal of sequencing the whole human genome. The magnitude of what that meant was near science fiction in the minds of many people, but not to the researchers lead by Dr Fraser. She gave them the infrastructure to collaborate and apply multi-disciplinary team science and empowered them to think big. Most importantly though, she challenged them to ask the right questions which is the root of scientific progress and success. This era of revolutionary science was amplified by controversy when TIGR founder, J. Craig Venter, left to start private company Celera Genomics. Celera announced they would compete with the HGP to be the first to deliver a fully sequenced human genome. There was now a race in DNA Valley between public and private research teams to accomplish the remarkable. The HGP was lead by researchers from NIH at what would become National Human Genome Research Institute directed by Dr Francis Collins and at TIGR, lead by President and Director Dr Claire Fraser. However, it was in 1995 that TIGR quickly became the world’s leader in the new field of microbial genomics after a group of investigators, using a new approach, reported on the first complete genome sequence of a free-living organism, and changed the field of microbiology forever. TIGR can take credit for playing a key role in the sequencing and analysis of the first plant species, Arabidopsis thaliana, and the first human-pathogenic parasite, Plasmodium falciparum. By 2000 it was declared that both sides had won, and each produced a working draft of the genome, and a long list of other scientific breakthroughs that further solidified DNA Valley as the place to be to bring forth the future of genetics.
A Legacy Continues:Now after a decade at IGS, Dr Fraser continues to empower researchers to march towards new frontiers of genomics, both at the Institute and around the world. As she leads the institute forward, many still look at IGS as a reflection of where it all began. In fact, Elodie Ghedin, PhD (@eghedin) from NYU shared that all TIGER Alumni feel kinship to IGS, and she personally credits Dr Fraser to the direction she took her career. UMB President, Jay A. Perman, MD, closed the day’s celebration by crediting the institution’s deep dedication to basic and translational research for it’s uniquely powerful influence on how we understand the basis of life, and how we use that understanding to save human life. “IGS proudly makes UMB better”, Perman proclaimed, “and we thank Dr Fraser for teaching us how to ask the right questions and work together.” Perhaps it was the right questions, combined with the right amount of competition that 20 years ago fueled the scientific discoveries which made our region DNA Valley and changed the future of medicine. Whatever the next frontier is, you can be sure that ‘The Big House’ in genomics will play a role, and it will have a foundation here in Maryland. ***** The Institute for Genome Sciences is located at the UM BIoPark in Baltimore, MD. For more on the IGS visit http://www.igs.umaryland.edu
The following two tabs change content below.
Over the past 8 years, Chris has grown BioBuzz into a respected brand that is recognized for its community building, networking events and news stories about the local biotech industry. In addition, he runs a Recruiting and Marketing Agency that helps companies attract top talent through a blended model that combines employer branding and marketing services together with a high powered recruiting solution.
Latest posts by Chris Frew (see all)
- Viela Bio Receives U.S. FDA Breakthrough Therapy Designation for Inebilizumab for Treatment of Neuromyelitis Optica Spectrum Disorder - April 18, 2019
- REGENXBIO Appoints Dr. Steve Pakola as Chief Medical Officer - April 17, 2019
- BioTalk Podcast – Live from the BioHealth Capital Region Forum - April 16, 2019